APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exoglucanase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exoglucanase Market Outlook and Growth Opportunities 2026

Report ID 173265080428 December 2025193 pages

Choose your research edition.

Industry ResearchExoglucanase Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Exoglucanase Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Exoglucanase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exoglucanase Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Exoglucanase Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Exoglucanase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exoglucanase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exoglucanase market include Mitsubishi Chemical, DuPont, BASF, Ultreze, Sunson Industry, Specialty Enzymes & Probiotics, Novozymes, KeyGene and Infinita Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exoglucanase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exoglucanase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exoglucanase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exoglucanase market size, projected growth trends, production technologies, key applications, and end-use industries.

Exoglucanase Segment by Company

Mitsubishi Chemical

DuPont

BASF

Ultreze

Sunson Industry

Specialty Enzymes & Probiotics

Novozymes

KeyGene

Infinita Biotech

ENMEX

DuPont Industrial Biosciences

DSM

BIO-CAT

Amano Enzyme

AB Enzymes

Exoglucanase Segment by Type

Cutting to the Reduction End

Cutting to the Non-Reduction End

Exoglucanase Segment by Application

Food and Brewing Industry

Biomedical Material Synthesis

Lignocellulose Conversion

Extreme Environment Bioprocessing

Other

Exoglucanase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exoglucanase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Exoglucanase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exoglucanase significant trends, drivers, influence factors in global and regions.

6. To analyze Exoglucanase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoglucanase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoglucanase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoglucanase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exoglucanase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exoglucanase industry.

Chapter 3: Detailed analysis of Exoglucanase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Exoglucanase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Exoglucanase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exoglucanase Industry Trends Table 2. Exoglucanase Industry Drivers Table 3. Exoglucanase Industry Opportunities and Challenges Table 4. Exoglucanase Industry Restraints Table 5. Global Exoglucanase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exoglucanase Revenue Share by Company (2021-2026) Table 7. Global Exoglucanase Sales Volume by Company (t) & (2021-2026) Table 8. Global Exoglucanase Sales Volume Share by Company (2021-2026) Table 9. Global Exoglucanase Average Price (USD/kg) of Company (2021-2026) Table 10. Global Exoglucanase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Exoglucanase Key Company Manufacturing Base & Headquarters Table 12. Global Exoglucanase Company, Product Type & Application Table 13. Global Exoglucanase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Exoglucanase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cutting to the Reduction End Table 18. Significant Companies of Cutting to the Non-Reduction End Table 19. Global Exoglucanase Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Exoglucanase Sales Volume by Type (2021-2026) & (t) Table 21. Global Exoglucanase Sales Volume by Type (2027-2032) & (t) Table 22. Global Exoglucanase Sales Volume Share by Type (2021-2026) Table 23. Global Exoglucanase Sales Volume Share by Type (2027-2032) Table 24. Global Exoglucanase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Exoglucanase Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Exoglucanase Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Exoglucanase Sales Value Share by Type (2021-2026) Table 28. Global Exoglucanase Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Food and Brewing Industry Table 30. Significant Companies of Biomedical Material Synthesis Table 31. Significant Companies of Lignocellulose Conversion Table 32. Significant Companies of Extreme Environment Bioprocessing Table 33. Significant Companies of Other Table 34. Global Exoglucanase Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Exoglucanase Sales Volume by Application (2021-2026) & (t) Table 36. Global Exoglucanase Sales Volume by Application (2027-2032) & (t) Table 37. Global Exoglucanase Sales Volume Share by Application (2021-2026) Table 38. Global Exoglucanase Sales Volume Share by Application (2027-2032) Table 39. Global Exoglucanase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Exoglucanase Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Exoglucanase Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Exoglucanase Sales Value Share by Application (2021-2026) Table 43. Global Exoglucanase Sales Value Share by Application (2027-2032) Table 44. Global Exoglucanase Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Exoglucanase Sales by Region (2021-2026) & (t) Table 46. Global Exoglucanase Sales Market Share by Region (2021-2026) Table 47. Global Exoglucanase Sales by Region (2027-2032) & (t) Table 48. Global Exoglucanase Sales Market Share by Region (2027-2032) Table 49. Global Exoglucanase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Exoglucanase Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Exoglucanase Sales Value Share by Region (2021-2026) Table 52. Global Exoglucanase Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Exoglucanase Sales Value Share by Region (2027-2032) Table 54. Global Exoglucanase Market Average Price (USD/kg) by Region (2021-2026) Table 55. Global Exoglucanase Market Average Price (USD/kg) by Region (2027-2032) Table 56. Global Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Exoglucanase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Exoglucanase Sales by Country (2021-2026) & (t) Table 59. Global Exoglucanase Sales Market Share by Country (2021-2026) Table 60. Global Exoglucanase Sales by Country (2027-2032) & (t) Table 61. Global Exoglucanase Sales Market Share by Country (2027-2032) Table 62. Global Exoglucanase Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Exoglucanase Sales Value Market Share by Country (2021-2026) Table 64. Global Exoglucanase Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Exoglucanase Sales Value Market Share by Country (2027-2032) Table 66. Mitsubishi Chemical Company Information Table 67. Mitsubishi Chemical Business Overview Table 68. Mitsubishi Chemical Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. Mitsubishi Chemical Exoglucanase Product Portfolio Table 70. Mitsubishi Chemical Recent Development Table 71. DuPont Company Information Table 72. DuPont Business Overview Table 73. DuPont Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. DuPont Exoglucanase Product Portfolio Table 75. DuPont Recent Development Table 76. BASF Company Information Table 77. BASF Business Overview Table 78. BASF Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. BASF Exoglucanase Product Portfolio Table 80. BASF Recent Development Table 81. Ultreze Company Information Table 82. Ultreze Business Overview Table 83. Ultreze Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Ultreze Exoglucanase Product Portfolio Table 85. Ultreze Recent Development Table 86. Sunson Industry Company Information Table 87. Sunson Industry Business Overview Table 88. Sunson Industry Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Sunson Industry Exoglucanase Product Portfolio Table 90. Sunson Industry Recent Development Table 91. Specialty Enzymes & Probiotics Company Information Table 92. Specialty Enzymes & Probiotics Business Overview Table 93. Specialty Enzymes & Probiotics Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Specialty Enzymes & Probiotics Exoglucanase Product Portfolio Table 95. Specialty Enzymes & Probiotics Recent Development Table 96. Novozymes Company Information Table 97. Novozymes Business Overview Table 98. Novozymes Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Novozymes Exoglucanase Product Portfolio Table 100. Novozymes Recent Development Table 101. KeyGene Company Information Table 102. KeyGene Business Overview Table 103. KeyGene Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. KeyGene Exoglucanase Product Portfolio Table 105. KeyGene Recent Development Table 106. Infinita Biotech Company Information Table 107. Infinita Biotech Business Overview Table 108. Infinita Biotech Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Infinita Biotech Exoglucanase Product Portfolio Table 110. Infinita Biotech Recent Development Table 111. ENMEX Company Information Table 112. ENMEX Business Overview Table 113. ENMEX Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. ENMEX Exoglucanase Product Portfolio Table 115. ENMEX Recent Development Table 116. DuPont Industrial Biosciences Company Information Table 117. DuPont Industrial Biosciences Business Overview Table 118. DuPont Industrial Biosciences Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. DuPont Industrial Biosciences Exoglucanase Product Portfolio Table 120. DuPont Industrial Biosciences Recent Development Table 121. DSM Company Information Table 122. DSM Business Overview Table 123. DSM Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. DSM Exoglucanase Product Portfolio Table 125. DSM Recent Development Table 126. BIO-CAT Company Information Table 127. BIO-CAT Business Overview Table 128. BIO-CAT Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. BIO-CAT Exoglucanase Product Portfolio Table 130. BIO-CAT Recent Development Table 131. Amano Enzyme Company Information Table 132. Amano Enzyme Business Overview Table 133. Amano Enzyme Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. Amano Enzyme Exoglucanase Product Portfolio Table 135. Amano Enzyme Recent Development Table 136. AB Enzymes Company Information Table 137. AB Enzymes Business Overview Table 138. AB Enzymes Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 139. AB Enzymes Exoglucanase Product Portfolio Table 140. AB Enzymes Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Exoglucanase Distributors List Table 144. Exoglucanase Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Exoglucanase Product Image Figure 2. Global Exoglucanase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Exoglucanase Sales (2021-2032) & (t) Figure 5. Global Exoglucanase Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Exoglucanase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cutting to the Reduction End Image Figure 10. Cutting to the Non-Reduction End Image Figure 11. Global Exoglucanase Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Exoglucanase Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Exoglucanase Sales Volume Share by Type (2021-2032) Figure 14. Global Exoglucanase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Exoglucanase Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Exoglucanase Sales Value Share by Type (2021-2032) Figure 17. Food and Brewing Industry Image Figure 18. Biomedical Material Synthesis Image Figure 19. Lignocellulose Conversion Image Figure 20. Extreme Environment Bioprocessing Image Figure 21. Other Image Figure 22. Global Exoglucanase Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Exoglucanase Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Exoglucanase Sales Volume Share by Application (2021-2032) Figure 25. Global Exoglucanase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Exoglucanase Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Exoglucanase Sales Value Share by Application (2021-2032) Figure 28. Global Exoglucanase Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Exoglucanase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Exoglucanase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Exoglucanase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 33. North America Exoglucanase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Exoglucanase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Exoglucanase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 39. South America Exoglucanase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Exoglucanase Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Exoglucanase Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Exoglucanase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Exoglucanase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Exoglucanase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Exoglucanase Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Exoglucanase Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Cutting to the Reduction End
  • Cutting to the Non-Reduction End
Applications
  • Food and Brewing Industry
  • Biomedical Material Synthesis
  • Lignocellulose Conversion
  • Extreme Environment Bioprocessing
  • Other
Companies covered
  • Mitsubishi Chemical
  • DuPont
  • BASF
  • Ultreze
  • Sunson Industry
  • Specialty Enzymes & Probiotics
  • Novozymes
  • KeyGene
  • Infinita Biotech
  • ENMEX
  • DuPont Industrial Biosciences
  • DSM
  • BIO-CAT
  • Amano Enzyme
  • AB Enzymes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoglucanase Sales Value (2021-2032)
  4. 1.2.2 Global Exoglucanase Sales Volume (2021-2032)
  5. 1.2.3 Global Exoglucanase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Exoglucanase Market Dynamics
  1. 2.1 Exoglucanase Industry Trends
  2. 2.2 Exoglucanase Industry Drivers
  3. 2.3 Exoglucanase Industry Opportunities and Challenges
  4. 2.4 Exoglucanase Industry Restraints
3 Exoglucanase Market by Company
  1. 3.1 Global Exoglucanase Company Revenue Ranking in 2025
  2. 3.2 Global Exoglucanase Revenue by Company (2021-2026)
  3. 3.3 Global Exoglucanase Sales Volume by Company (2021-2026)
  4. 3.4 Global Exoglucanase Average Price by Company (2021-2026)
  5. 3.5 Global Exoglucanase Company Ranking (2024-2026)
  6. 3.6 Global Exoglucanase Company Manufacturing Base and Headquarters
  7. 3.7 Global Exoglucanase Company Product Type and Application
  8. 3.8 Global Exoglucanase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Exoglucanase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Exoglucanase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Exoglucanase Market by Type
  1. 4.1 Exoglucanase Type Introduction
  2. 4.1.1 Cutting to the Reduction End
  3. 4.1.2 Cutting to the Non-Reduction End
  4. 4.2 Global Exoglucanase Sales Volume by Type
  5. 4.2.1 Global Exoglucanase Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Exoglucanase Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Exoglucanase Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Exoglucanase Sales Value by Type
  9. 4.3.1 Global Exoglucanase Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Exoglucanase Sales Value by Type (2021-2032)
  11. 4.3.3 Global Exoglucanase Sales Value Share by Type (2021-2032)
5 Exoglucanase Market by Application
  1. 5.1 Exoglucanase Application Introduction
  2. 5.1.1 Food and Brewing Industry
  3. 5.1.2 Biomedical Material Synthesis
  4. 5.1.3 Lignocellulose Conversion
  5. 5.1.4 Extreme Environment Bioprocessing
  6. 5.1.5 Other
  7. 5.2 Global Exoglucanase Sales Volume by Application
  8. 5.2.1 Global Exoglucanase Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Exoglucanase Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Exoglucanase Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Exoglucanase Sales Value by Application
  12. 5.3.1 Global Exoglucanase Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Exoglucanase Sales Value by Application (2021-2032)
  14. 5.3.3 Global Exoglucanase Sales Value Share by Application (2021-2032)
6 Exoglucanase Regional Sales and Value Analysis
  1. 6.1 Global Exoglucanase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exoglucanase Sales by Region (2021-2032)
  3. 6.2.1 Global Exoglucanase Sales by Region: 2021-2026
  4. 6.2.2 Global Exoglucanase Sales by Region (2027-2032)
  5. 6.3 Global Exoglucanase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Exoglucanase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Exoglucanase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Exoglucanase Sales Value by Region (2027-2032)
  9. 6.5 Global Exoglucanase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Exoglucanase Sales Value (2021-2032)
  12. 6.6.2 North America Exoglucanase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Exoglucanase Sales Value (2021-2032)
  15. 6.7.2 Europe Exoglucanase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Exoglucanase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Exoglucanase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Exoglucanase Sales Value (2021-2032)
  21. 6.9.2 South America Exoglucanase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Exoglucanase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Exoglucanase Sales Value Share by Country, 2025 VS 2032
7 Exoglucanase Country-level Sales and Value Analysis
  1. 7.1 Global Exoglucanase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exoglucanase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Exoglucanase Sales by Country (2021-2032)
  4. 7.3.1 Global Exoglucanase Sales by Country (2021-2026)
  5. 7.3.2 Global Exoglucanase Sales by Country (2027-2032)
  6. 7.4 Global Exoglucanase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Exoglucanase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Exoglucanase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Exoglucanase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Exoglucanase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Exoglucanase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Exoglucanase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Exoglucanase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Exoglucanase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Exoglucanase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Exoglucanase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Exoglucanase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Exoglucanase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Exoglucanase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Exoglucanase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Exoglucanase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Exoglucanase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Exoglucanase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Exoglucanase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Exoglucanase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Exoglucanase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Exoglucanase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Exoglucanase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Exoglucanase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Exoglucanase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Exoglucanase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Exoglucanase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Exoglucanase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Exoglucanase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Exoglucanase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Exoglucanase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Exoglucanase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Exoglucanase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Exoglucanase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Exoglucanase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Exoglucanase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Exoglucanase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Exoglucanase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Exoglucanase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Exoglucanase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Exoglucanase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Exoglucanase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Exoglucanase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Exoglucanase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Exoglucanase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Exoglucanase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Exoglucanase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Exoglucanase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Exoglucanase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Exoglucanase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Exoglucanase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Exoglucanase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Exoglucanase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Exoglucanase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Exoglucanase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Exoglucanase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Exoglucanase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Exoglucanase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Exoglucanase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Exoglucanase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Exoglucanase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Exoglucanase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Exoglucanase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Exoglucanase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Exoglucanase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Exoglucanase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Exoglucanase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Exoglucanase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Exoglucanase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Exoglucanase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Exoglucanase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Exoglucanase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Exoglucanase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Exoglucanase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Exoglucanase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Exoglucanase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Exoglucanase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Exoglucanase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Exoglucanase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Exoglucanase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Exoglucanase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Exoglucanase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Exoglucanase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Exoglucanase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Exoglucanase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Exoglucanase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Exoglucanase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mitsubishi Chemical
  2. 8.1.1 Mitsubishi Chemical Company Information
  3. 8.1.2 Mitsubishi Chemical Business Overview
  4. 8.1.3 Mitsubishi Chemical Exoglucanase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mitsubishi Chemical Exoglucanase Product Portfolio
  6. 8.1.5 Mitsubishi Chemical Recent Developments
  7. 8.2 DuPont
  8. 8.2.1 DuPont Company Information
  9. 8.2.2 DuPont Business Overview
  10. 8.2.3 DuPont Exoglucanase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DuPont Exoglucanase Product Portfolio
  12. 8.2.5 DuPont Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Exoglucanase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BASF Exoglucanase Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Ultreze
  20. 8.4.1 Ultreze Company Information
  21. 8.4.2 Ultreze Business Overview
  22. 8.4.3 Ultreze Exoglucanase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ultreze Exoglucanase Product Portfolio
  24. 8.4.5 Ultreze Recent Developments
  25. 8.5 Sunson Industry
  26. 8.5.1 Sunson Industry Company Information
  27. 8.5.2 Sunson Industry Business Overview
  28. 8.5.3 Sunson Industry Exoglucanase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sunson Industry Exoglucanase Product Portfolio
  30. 8.5.5 Sunson Industry Recent Developments
  31. 8.6 Specialty Enzymes & Probiotics
  32. 8.6.1 Specialty Enzymes & Probiotics Company Information
  33. 8.6.2 Specialty Enzymes & Probiotics Business Overview
  34. 8.6.3 Specialty Enzymes & Probiotics Exoglucanase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Specialty Enzymes & Probiotics Exoglucanase Product Portfolio
  36. 8.6.5 Specialty Enzymes & Probiotics Recent Developments
  37. 8.7 Novozymes
  38. 8.7.1 Novozymes Company Information
  39. 8.7.2 Novozymes Business Overview
  40. 8.7.3 Novozymes Exoglucanase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novozymes Exoglucanase Product Portfolio
  42. 8.7.5 Novozymes Recent Developments
  43. 8.8 KeyGene
  44. 8.8.1 KeyGene Company Information
  45. 8.8.2 KeyGene Business Overview
  46. 8.8.3 KeyGene Exoglucanase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 KeyGene Exoglucanase Product Portfolio
  48. 8.8.5 KeyGene Recent Developments
  49. 8.9 Infinita Biotech
  50. 8.9.1 Infinita Biotech Company Information
  51. 8.9.2 Infinita Biotech Business Overview
  52. 8.9.3 Infinita Biotech Exoglucanase Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Infinita Biotech Exoglucanase Product Portfolio
  54. 8.9.5 Infinita Biotech Recent Developments
  55. 8.10 ENMEX
  56. 8.10.1 ENMEX Company Information
  57. 8.10.2 ENMEX Business Overview
  58. 8.10.3 ENMEX Exoglucanase Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ENMEX Exoglucanase Product Portfolio
  60. 8.10.5 ENMEX Recent Developments
  61. 8.11 DuPont Industrial Biosciences
  62. 8.11.1 DuPont Industrial Biosciences Company Information
  63. 8.11.2 DuPont Industrial Biosciences Business Overview
  64. 8.11.3 DuPont Industrial Biosciences Exoglucanase Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 DuPont Industrial Biosciences Exoglucanase Product Portfolio
  66. 8.11.5 DuPont Industrial Biosciences Recent Developments
  67. 8.12 DSM
  68. 8.12.1 DSM Company Information
  69. 8.12.2 DSM Business Overview
  70. 8.12.3 DSM Exoglucanase Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 DSM Exoglucanase Product Portfolio
  72. 8.12.5 DSM Recent Developments
  73. 8.13 BIO-CAT
  74. 8.13.1 BIO-CAT Company Information
  75. 8.13.2 BIO-CAT Business Overview
  76. 8.13.3 BIO-CAT Exoglucanase Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BIO-CAT Exoglucanase Product Portfolio
  78. 8.13.5 BIO-CAT Recent Developments
  79. 8.14 Amano Enzyme
  80. 8.14.1 Amano Enzyme Company Information
  81. 8.14.2 Amano Enzyme Business Overview
  82. 8.14.3 Amano Enzyme Exoglucanase Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Amano Enzyme Exoglucanase Product Portfolio
  84. 8.14.5 Amano Enzyme Recent Developments
  85. 8.15 AB Enzymes
  86. 8.15.1 AB Enzymes Company Information
  87. 8.15.2 AB Enzymes Business Overview
  88. 8.15.3 AB Enzymes Exoglucanase Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 AB Enzymes Exoglucanase Product Portfolio
  90. 8.15.5 AB Enzymes Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exoglucanase Value Chain Analysis
  2. 9.1.1 Exoglucanase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exoglucanase Sales Mode & Process
  6. 9.2 Exoglucanase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exoglucanase Distributors
  9. 9.2.3 Exoglucanase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst